Clinical Trial Update: Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated bevacizumab (Avastin) in combination with radiotherapy for elderly patients with glioblastoma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: University of Zurich | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED